HOUSTON--(BUSINESS WIRE)--Orion S.A. (NYSE: OEC), a specialty chemical company, today announced financial results for the period ended June 30, 2025 as follows: Second Quarter 2025 Highlights Net sales of $466.4 million, down $10.6 million year over year Net income of $9.0 million, down $11.5 million year over year Diluted EPS of $0.16, down $0.19 year over year Adjusted EBITDA1 of $68.8 million, down 8% year over year Adjusted Diluted EPS1 of $0.32, down $0.09 year over year Six Months 2025 H
Related Questions
Will management provide guidance for FY 2025 given the recent performance?
What caused the YoY decline in net sales and net income for Q2 2025?
What is the company’s cash conversion and liquidity position after the recent quarter?
Has there been any change in the company's capex or R&D spending plans for 2025?
What is the outlook for margins and cost structure in the coming quarters?
How might the reduced diluted EPS affect potential dividend policy or share repurchase plans?
How does the 8% drop in Adjusted EBITDA compare to peers in the specialty chemicals sector?
What, if any, are the implications for the stock’s price target and valuation multiples?
Are there any notable macro‑economic or industry headwinds impacting Orion’s performance?
Do the results trigger any revisions to earnings forecasts from analysts?